Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.

Share this video  

IMW 2019 | Double oncogenic hits of 17p13(del) and 1q21(amp) in myeloma

Phaik Ju Teoh • 15 Sep 2019
IMW 2019
Multiple Myeloma

Dr. Phaik Ju Teoh, PhD, of the Cancer Science Institute of Singapore, Singapore explains her research on the prognosis of multiple myeloma patients harboring double oncogenic hits of 17p13(del) and 1q21(amp). This interview was recorded at the International Myeloma Workshop (IMW) 2019, in Boston, MA.

More from Phaik Ju Teoh

The influence of IL6R-ADAR1-STAT3 interplay on MM prognosis 3:14
The influence of IL6R-ADAR1-STAT3 interplay on MM prognosis
Phaik Ju Teoh • 15 Sep 2019

Related Videos

Belantamab mafodotin in functional high-risk RRMM: subgroup analysis of DREAMM-7 and DREAMM-8 4:02
Belantamab mafodotin in functional high-risk RRMM: subgroup analysis of DREAMM-7 and DREAMM-8
Meral Beksac • 10 Dec 2025
Incidence and risk factors for infections in NDMM treated with modern induction regimens 1:54
Incidence and risk factors for infections in NDMM treated with modern induction regimens
Efstathios Kastritis • 7 Dec 2025
A real-world analysis of infections in patients with RRMM receiving ide-cel 3:59
A real-world analysis of infections in patients with RRMM receiving ide-cel
Muhammad Bilal Abid • 6 Dec 2025
Integrating molecular diagnostics in smoldering myeloma to predict disease progression 1:37
Integrating molecular diagnostics in smoldering myeloma to predict disease progression
Gareth Morgan • 7 Dec 2025
The content of VJHemOnc is intended for healthcare professionals